Vitalist Inc · TSXV:VITA
Vitalist — Investor Presentation (October 2026)
17 slides from Vitalist's investor presentation, October 2026
Slide 1: Pioneering a flexible, developer-friendly ecosystem that revolutionizes wearables
Pioneering a flexible, developer-friendly ecosystem that revolutionizes wearables design and performance Vitalist Inc. (TSX-V: VITA-V, OTCQB: VTLSF) Corporate Presentation October 2026
Slide 2: Important Disclaimers & Forward-Looking Statements
Important Disclaimers & Forward-Looking Statements 2 CONFIDENTIALITY & GENERAL DISCLAIMER This presentation is not, and under no circumstances is to be construed as, a prospectus, an advertisement, or a public offering of securities of Vitalist Inc. (“Vitalist” or the “Company”). Neither the TSX Ven
Slide 3: Why Vitalist
3 Why Vitalist Vitalist is pioneering an open, developer-friendly ecosystem with its innovative wearable software platform, VitalOSTM, and partnering with major brands to enable to creation of next generation wearable design, performance, and battery life. Proprietary Commercial High-Margin Scalable
Slide 4: Global Wearables Market
4 Global Wearables Market Fastest Growing 2025 Market Value CAGR 2026 - 2033 2033 Market Value Largest Market Market US$92.9 Billion1 12.1%1 US$229.9 Billion1 North America1 Asia Pacific 2025 Product Segmentation3 2025 Channel Segmentation1,2 2025 Regional Segmentation4 1 Grandview Research 2026 (Ac
Slide 5: Core Tech & Value Proposition
5 Core Tech & Value Proposition Delivering “Apple-quality” user experience on easily deployable, low-resource, cost-effective silicon. Low BOM Cost 7–10 Day Battery Life1 Rapid Brand Spin-Up VitalOS runs on accessible microcontrollers Multi-day runtime vs. 1–2 day standard Turnkey launches, with fas
Slide 6: Commercial Engine
6 Commercial Engine The Market Impact A unified OS architecture ensuring that whether a user is an athlete, a timepiece enthusiast, or a clinical patient, their data is handled with high-grade security and unmatched battery efficiency. Consumer Goods Healthcare OEMs Drastically lowering the barrier
Slide 7: Consumer Goods
7 Consumer Goods Strategy Partnering with prominent brands to deploy smart wearable products using the VitalOS platform, to generate revenue and evidence the efficacy of the VitalOS platform. Execution Wearables Market Value by Channel (US$ Billions)1,2 Brand Partner: Revenue Model: Design, produce,
Slide 8: Reebok 2026/27 Product Line
8 Reebok 2026/27 Product Line Flagship Limited Edition RUSH Stride Kinetic Allen Iverson Pulse Icon $79.99 $99.99 $224.99 $249.99 $139.99 $119.99 USD MSRP USD MSRP USD MSRP USD MSRP USD MSRP USD MSRP In Stores Now October 2026 April 2027 In Stores Now
Slide 9: Health Care
9 Health Care Strategy Partner with health providers and remote patient monitoring ("RPM") companies to enable them to provide their patients a smart wearable device for their healthcare utilizing the VitalOS platform, with a goal to generate recurring revenue via SaaS, unit sales and monthly monito
Slide 10: RPM 2026/27 Product Line
10 RPM 2026/27 Product Line FLAGSHIP NEXT-GEN Lenz Prime $TBD USD MSRP $TBD USD MSRP Available colors: Available colors: TBD
Slide 11: Original Equipment Manufacturer
11 Original Equipment Manufacturer Strategy Identify and sell VitalOS as a firmware platform solution to wearable OEM's, with the goal of enabling manufacturers, brands, and other businesses to easily and cost effectively spin up new wearable products using VitalOS. Execution Technical Partner: Reve
Slide 12: Key Milestones and Growth Strategy
12 Key Milestones and Growth Strategy Track Record of Execution Upcoming Catalysts & Milestones Secured 5-year brand licensing agreement for Reebok smartwatches in North and Signed exclusive Reebok 2025 - Q2 South America with Authentic Brands Group, unlocking a tier-1 brand to validate 2026 - Q4 Co
Slide 13: Meet Our Leadership
13 Meet Our Leadership Kalvie Legat Carley George David Colleran, CPA Charles Herman, M.D. Sean Croft CEO and Director, Kalvie President, Carley is a sales CFO, David has over 17 CSO, Dr. Herman is a surgeon CPO, Sean Croft brings offers over 20 years of and marketing professional years of experienc
Slide 14: Meet Our Board
14 Meet Our Board Jared Wolk, CFA Joanne Hruska, CFA, ICD.D John Harding, M.D. Tyler Rice, CPA, MPAcc Tony Natale Jared Wolk serves as the Portfolio Joanne Hruska serves as the Dr. Harding is a board-certified Tyler Rice is the Founding Partner Tony Natale joined Vitalist's Board of Manager for Vesta
Slide 15: Vitalist Inc: Capitalization Overview
15 Vitalist Inc: Capitalization Overview This slide provides a summary of Vitalist Inc.'s capitalization structure. Common Shares Outstanding 1 66,763,533 Options 1 6,025,000 Warrants 1 6,460,720 Fully Diluted Shares Outstanding 79,249,253 Royalty Units 2 6,355,200 Debt 5 $9.32 million Market Capita
Slide 16: Vitalist Inc: Debt Overview
16 Vitalist Inc: Debt Overview (All figures in $CAD as at June 30, 2026). Accounting Value Full Cash Value w/ Interest Debenture notes 1 $4.00 million $6.29 million Fixed term loan held by largest equity holder; currently 0% interest Credit facility - (CAD & USD) 2, 3 $4.00 million $4.93 million $12
Slide 17: Vitalist Inc. | TSXV: VITA | OTCQB: VTLSF
Vitalist Inc. | TSXV: VITA | OTCQB: VTLSF PHONE +1 (403) 560-9635 WEBSITE www.vitalist.ca EMAIL [email protected] ADDRESS Vitalist Inc. - 222 3rd Avenue SW, Calgary. Alberta,Canada Vitalist Health - 3 Columbus Circle, 15th Floor New York, NY INVESTOR RELATIONS Walter Frank IMS Investor Relations vitali